Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03YUT
|
||||
| Former ID |
DNC013313
|
||||
| Drug Name |
2-chloro-1-(5-(pyridin-2-yl)oxazol-2-yl)ethanone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528884] | ||
| Formula |
C10H7ClN2O2
|
||||
| Canonical SMILES |
C1=CC=NC(=C1)C2=CN=C(O2)C(=O)CCl
|
||||
| InChI |
1S/C10H7ClN2O2/c11-5-8(14)10-13-6-9(15-10)7-3-1-2-4-12-7/h1-4,6H,5H2
|
||||
| InChIKey |
MKVLXIACPLGLLP-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [528884] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.